US4708952AExpiredUtility

Method of treatment of the infectious and viral diseases by one time interference

Assignee: SALATINJANTS AIDAPriority: Feb 6, 1985Filed: Mar 31, 1986Granted: Nov 24, 1987
Est. expiryFeb 6, 2005(expired)· nominal 20-yr term from priority
A61K 31/635Y02A50/30A61K 47/12A61K 31/49
73
PatentIndex Score
63
Cited by
9
References
4
Claims

Abstract

A composition adapted to prolong the residence time of sulfa and cinchona alkaloid drugs in the circulating plasma of mammals including humans comprising hexanoic acid, potassium hydrogen tartrate, tannic acid, pectin and riboflavin, with the further presence of glutamic acid in the case of sulfa drugs and L-tyrosine in the case of the cinchona alkaloids.

Claims

exact text as granted — not AI-modified
I claim: 
     
       1. A composition adapted to prolong the residence time of drugs in the circulating plasma of mammals including humans comprising about 6 parts by weight hexanoic acid, about 48 parts by weight potassium hydrogen tartrate, about 8 parts by weight tannic acid, about 94 parts by weight pectin, about 200 parts by weight of 10% riboflavin, and about 21 parts by weight glutamic acid. 
     
     
       2. The composition of claim 1, in the form of an aqueous solution. 
     
     
       3. The composition of claim 1 containing an effective amount of a sulfa drug. 
     
     
       4. The method of treating dysentery which comprises administering to a mammal suffering dysentery a composition comprising an effective amount of a sulfa drug in combination with a composition adapted to prolong the residence time of drugs in the circulating plasma of mammals including humans comprising about 6 parts by weight hexanoic acid, about 48 parts by weight potassium hydrogen tartrate, about 8 parts by weight tannic acid, about 94 parts by weight pectin, about 200 parts by weight of 10% riboflavin and about 21 parts by weight glutamic acid.

Join the waitlist — get patent alerts

Track US4708952A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.